Chris Finkenstadt

Chris Finkenstadt serves as a key procurement professional within the W40M MRC0 West agency under the Department of the Army, responsible for acquiring critical medical readiness capabilities that support operational field medicine. He manages a portfolio of contracts focused on in-vitro diagnostic substances, electromedical devices, laboratory instrumentation, and blood management systems essential for high-acuity combat care. His work ensures the Army’s medical forces maintain sovereign diagnostic and therapeutic capabilities in austere environments, aligning directly with the agency’s mission of sustaining military medical sovereignty through advanced, deployable healthcare technologies. Finkenstadt maintains consistent contracting relationships with leading medical technology providers including Roche Diagnostics Corporation, Abbott Molecular Inc., Cardinal Health 414, LLC, Surgical Neuromonitoring Associates, Inc., and Premier Shockwave, Inc. These partnerships reflect a preference for established industry leaders with proven capabilities in FDA-regulated medical devices, molecular diagnostics, and sterilization systems. His contracting patterns emphasize technical rigor, regulatory compliance, and supply chain reliability, often leveraging blanket purchase agreements and indefinite-delivery/indefinite-quantity contracts to ensure rapid field deployment. His procurement strategy prioritizes open competition, with 76.5% of awards issued without set-aside, while maintaining a meaningful commitment to small business participation—20.6% of contracts are awarded under total small business set-asides, and 2.9% under 8(a) competed programs. This balance reflects a deliberate effort to integrate innovative small businesses without compromising mission-critical performance standards. Finkenstadt’s primary technical focus lies in NAICS 325413 (in-vitro diagnostic substance manufacturing) and 334516 (analytical laboratory instrument manufacturing), with significant activity in electromedical apparatus and precision equipment maintenance. His expertise centers on procuring molecular diagnostic kits, point-of-care analyzers, surgical monitoring systems, and sterilization equipment critical to forward-deployed medical units.